Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 19.06.2026 FCSG IE00BKPSPT20 800,002.00 USD 34,684,046.61 43.355  ...

TORONTO--(BUSINESS WIRE)--En tant que commanditaire officiel de la Coupe du Monde de la FIFA 2026MC, Dove tire parti de l’un des plus grands événements sportifs internationaux pour mettre en lumière les pressions souvent méconnues auxquelles se heurtent les filles dans le sport. Des études ayant révélé qu’une fille sur deux qui abandonne le sport a été critiquée pour son apparence corporelle, Dove lance la campagne #LeMatchEstANous. Cette initiative célèbre la confiance en soi, la connexion et...

TORONTO--(BUSINESS WIRE)--As an Official Sponsor of the FIFA World Cup 2026™, Dove is using one of the world’s biggest sporting moments to spotlight the often-unseen pressures girls face in sport. With research finding that 1 in 2 girls who quit sports have been criticized for their body type, Dove is launching #TheGameIsOurs to celebrate the confidence, connection and joy that help girls stay in the game they love. To bring this message to life, Dove is amplifying the voices of Canadian athlet...

CHICAGO--(BUSINESS WIRE)--Litera unveils how Kira delivered the contract intelligence Cvent needed to navigate its most significant deal on a compressed timeline...

GREENSBORO, N.C.--(BUSINESS WIRE)--With a robust, nationwide lineup of music festival sponsorships and immersive activations, Wrangler is bringing its Western heritage to the fans....

PHOENIX--(BUSINESS WIRE)--Centuri Holdings, Inc. (NYSE: CTRI) (“Centuri” or the "Company"), a leading, North American utility and energy infrastructure services company, today announced more than $360 million in new commercial awards. The bookings reflect the Company’s strategic efforts to grow the Company’s portfolio through both expanded and new customer relationships. New projects and new or expanded Master Services Agreements (MSAs) comprise approximately 43% of the award value, with the re...

GREENWICH, Conn.--(BUSINESS WIRE)--Littlejohn & Co., LLC (“Littlejohn”), a private investment firm based in Greenwich, CT, today announced the promotion of Charles Leung to Managing Director. Mr. Leung joined Littlejohn in 2013 as an Associate. Over the past 13 years, Mr. Leung has made significant contributions to Littlejohn, including his development of the firm’s capabilities and track record in the engineering and professional services sectors. He currently serves as a director at Ardur...

OTTAWA, Ontario--(BUSINESS WIRE)--Today, BioTalent Canada launched BioInsights, its new labour market intelligence (LMI) consulting service for the bio-economy — the essential decision intelligence resource for strategic planning, competitive advantage, attracting new investment, future growth ambitions and effective talent management. BioInsights is a professional LMI consulting service that is informed by BioTalent Canada’s multi-year data gathering, analysis and trends customized to individu...

GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--Empower, a leading provider of retirement and wealth management solutions,1 announced today they have renewed their contract with the Texa$averSM 401(k) / 457 Program of the Employees Retirement System of Texas (ERS). The six-year contract, which was approved by the ERS Board of Trustees, is effective Jan. 1, 2027, through Dec. 31, 2032. “With a local presence in Austin, TX, and relationships across 200+ state agencies and some higher education institu...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointment of Agnieszka “AJ” Jurecka, M.D., Ph.D., MPH, as Vice President, Medical Affairs. “We are delighted to welcome AJ to the Spruce executive team. She is a rare combination of practicing physician, scientist, and biopharmac...